{"nct_id":"NCT05309421","title":"A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-09-19","start_date_type":"ACTUAL","primary_completion_date":"2025-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["EVAX"]}